Clinical Trials Insight: 700016053
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2009
At a glance
- Drugs Panobacumab (Primary)
- Indications Nosocomial infections; Pseudomonal infections
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Kenta Biotech
- 01 Aug 2009 Results published in Antimicrobial Agents and Chemotherapy.
- 12 Oct 2006 New trial record.